47 computational-social-science PhD positions at University of Groningen in Netherlands
Sort by
Refine Your Search
-
the Jantina Tammes School of Digital Society, Technology and AI. ELSA4TI focuses on the ethical, legal, social and economic implications of AI adoption in the technical industry. This PhD position focuses
-
, journalistic innovation and the social construction of technology). - Having experience with and/or knowledge in the proposed project area (ideally at master's level) is an asset. - Comprehension of one or more
-
Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description The Faculty of Spatial Sciences together with the Faculty of Science and
-
the NGF-Call AiNed ELSA Labs). The ELSA4TI Lab is led by Prof Ming Cao, Director of the Jantina Tammes School of Digital Society, Technology and AI. ELSA4TI focuses on the ethical, legal, social and
-
intrinsically motivated to pursue critical-historical research into digital journalism, journalistic innovation and the social construction of technology). Having experience with and/or knowledge in the proposed
-
The Faculty of Spatial Sciences together with the Faculty of Science and Engineering offer a 4-year M20 (Ubbo Emmius) Program funded PhD position for a project titled “Grassroots retrofitting
-
expected. - A PhD training programme is part of the agreement and the successful candidate will be enrolled in the Graduate School of Science and Engineering. The first possible starting date is 1 January
-
an international place of knowledge. Within the Faculty of Science and Engineering (FSE), the Engineering and Technology institute Groningen (ENTEG) is a multidisciplinary hub for engineering science and technology
-
(https://www.rug.nl/research/gradschool-science-and-engineering/phd-programme/admission/criteria?lang=en ). Conditions of employment We offer, following the Collective Labour Agreement for Dutch
-
spanning nanomedicine and fundamental science to social science; policy-makers, regulatory bodies; industry, patients and citizens) in order to accelerate and support the development of novel nanomedicines